The world’s most prestigious thinktank dedicated to advancing the most productive and quality years of life.

Watch our GHPI fellow Brian Kennedy, the President and CEO of The Buck Institute for research on aging along side Aubrey de Grey debating if lifespans are long enough.

Watch here: http://intelligencesquaredus.org/debates/past-debates/item/1…ong-enough
And don’t forget to let congress know that healthy lifespans are not long enough: http://tame.healthspanpolicy.org/

Help start a revolution in heathcare!

Sign onto our new letter of support and let your Senator know — the time is NOW to fund the first ever FDA approved research to target ALL the diseases of aging at once.

http://tame.healthspanpolicy.org/

Please help spread the word by sharing.

Global Healthspan Policy Institute added a new photo.

35 mins ·.

Read more

More than half of terminally ill blood cancer patients experienced complete remission in early clinical trials.

More info: http://ow.ly/YoWWv please help spread the word by sharing!

Read more

MIAMI, Sept. 10 (UPI) — The first patient to receive therapeutic delivery of islet cells in a new diabetes study no longer needs insulin therapy to control type 1 diabetes, according to doctors at the University of Miami’s Diabetes Research Institute.

The patient, Wendy Peacock, 43, has been giving herself insulin injections to control diabetes since she was diagnosed with the condition at age 17. Since she had the minimally-invasive procedure on August 18, Peacock has been off insulin, because her body is producing it naturally, and she no longer has the dietary restrictions that accompany type 1 diabetes.

Type 1 diabetes is caused by inadvertent destruction of insulin-producing islet cells in the pancreas by the immune system. While previous experimental treatments that involved the replacement of these cells has allowed patients to live without the need for insulin-replacement therapy for up to a decade, the goal is for better delivery of the cells to make the surgical treatment permanent — effectively curing the condition.

Read more

Custom-made, living body parts have been 3D-printed in a significant advance for regenerative medicine, say scientists.

The sections of bone, muscle and cartilage all functioned normally when implanted into animals.

The breakthrough, published in Nature Biotechnology, raises the hope of using living tissues to repair the body.

Read more

WIKIPEDIA, AYACOP Boosting levels of ghrelin, a hormone involved in hunger, keeps aging-related declines at bay in mice, according to a study published yesterday (February 2) in Molecular Psychiatry.

The authors gave mice a traditional Japanese medicine called rikkunshito or an extract from rikkunshito to stimulate hormone production. In three different mouse lines—two with shortened lifespans and another with a normal lifespan—the treatment resulted in the animals living longer.

“These findings suggest that the elevated endogenous ghrelin signaling has an important role in preventing aging-related premature death,” Akio Inui of Kagoshima University Graduate School of Medical and Dental Sciences and colleagues wrote in their report.

Read more

A group of scientists are calling on the WHO to classify aging as a disease, asserting that we need to create a better classification for what happens to our bodies as we get older.

A new controversy is brewing, as one group of scientists is recommending that aging be considered a disease.

Scientists from Insilico Medicine are highlighting the need to create a more granular and applied classification for what happens to our bodies when we age. Their work is outlined in a recent paper published in Frontiers in Genetics. The classification that they argue for is based on the World Health Organization’s (WHO) International Statistical Classification of Diseases and Related Health Problems (ICD-11), which is expected to be finalized in 2018.

Read more

The world’s most prestigious thinktank dedicated to advancing the most productive and quality years of life.

Read more